← Open Payments lookup

RAYMONDA RASTEGAR: Open Payments

NPI 1609888403 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$65,343 in 143 payments from 20 companies in 2025. Trend: 2023 $60,690 · 2024 $20,055 · 2025 $65,343

Speaker / faculty: $53,782Travel & lodging: $7,619Food & beverage: $3,941
CompanyPaymentsAmount
Novo Nordisk Inc33$62,647
AstraZeneca Pharmaceuticals LP13$366
Boehringer Ingelheim Pharmaceuticals, Inc.14$321
Merck Sharp & Dohme LLC9$228
Alnylam Pharmaceuticals Inc.9$226
Esperion Therapeutics, Inc.10$206
Lilly USA, LLC8$193
BIOTRONIK INC.1$161
Bayer Healthcare Pharmaceuticals Inc.5$156
BridgeBio Pharma, Inc.7$154

Products named: Ozempic, JARDIANCE, AMVUTTRA, VERQUVO, NEXLETOL, WAINUA, BIOMONITOR, LOKELMA.

Industry payments across NY — which companies pay providers there.